Compound information
- Natural Products
- ZC250294
- Molecular Formula
- C22H32N6O6
- Molecular Weight
- 476.238332744 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[[(2S)-1-[2-[benzyloxycarbonyl(methyl)amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C22H32N6O6/c1-27(22(33)34-14-15-7-3-2-4-8-15)13-18(29)28-12-6-10-17(28)19(30)26-16(20(31)32)9-5-11-25-21(23)24/h2-4,7-8,16-17H,5-6,9-14H2,1H3,(H,26,30)(H,31,32)(H4,23,24,25)/t16-,17-/m0/s1
- InChI Key
- PSXDICJGJXJQAQ-IRXDYDNUSA-N
- SMILES
- CN(CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(=O)OCc1ccccc1
- Source
- ZINC000015721267
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 2 |
Heteroatom Count | 12 | Rotatable Bond Count | 11 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 178.15 Å2 | LogP | -0.809 |
LogS | -2.617 | LogD | -0.496 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.996 |
HIA | 0.0 | F20 % | 0.0 |
F30 % | 0.0 | Caco-2 | -6.73 |
MDCK | -5.992 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.027 | PPB | 47.377 |
VD | 0.421 | Fu | 0.195 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.586 |
CYP2A6 substrate | 0.556 | CYP2B6 substrate | 0.618 |
CYP2C19 inhibitor | 0.092 | CYP2C19 substrate | 0.875 |
CYP2C8 substrate | 0.717 | CYP2C9 inhibitor | 0.045 |
CYP2C9 substrate | 0.998 | CYP2D6 inhibitor | 0.028 |
CYP2D6 substrate | 0.752 | CYP2E1 substrate | 0.266 |
CYP3A4 inhibitor | 0.013 | CYP3A4 substrate | 0.995 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.815 | CL | 4.771 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.405 | Hepatotoxicity | 0.225 |
Mutagenicity | 0.01 | Rat Oral Acute Toxicity | 0.051 |
FDAMDD | 0.327 | Skin Sensitization | 0.003 |
Carcinogenicity | 0.0 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.392 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.218 | IGC50 | 1.33 |
LC50FM | -4.049 | LC50DM | -2.61 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.565 | NR-AR-LBD | 0.316 |
NR-AhR | 0.007 | NR-Aromatase | 0.023 |
NR-ER | 0.362 | NR-ER-LBD | 0.389 |
NR-PPAR-gamma | 0.41 | SR-ARE | 0.048 |
SR-ATAD5 | 0.313 | SR-HSE | 0.135 |
SR-MMP | 0.007 | SR-p53 | 0.022 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.